Skip to main content
SpringerLink
Log in

Aufmerksamkeits-Defizit-/Hyperaktivitäts-Störungen

  • Chapter
Neuro-Psychopharmaka im Kindes- und Jugendalter

Zusammenfassung

Die Aufmerksamkeits-Defizit-/Hyperaktivitäts-Störung (ADHS) istgekennzeichnet durch ausgeprägte motorische Unruhe (Hyperaktivität), leistungsbeeinträchtigende Konzentrationsstörungen (Unaufmerksamkeit, erhöhte Ablenkbarkeit) sowie massive Schwierigkeiten, das eigene Verhalten zu planen und zu steuern (Impulskontrollstörung). Die Störung tritt situationsübergreifend in mindestens zwei Lebensbereichen (in Familie, in der Schule, am Spielplatz) auf und beginnt definitionsgemäß vor dem Alter von sechs Jahren. Die Symptomatik sollte über mehr als sechs Monate bestehen. Kinder mit ADHS sind in ihrer psychischen Entwicklung, schulischen und beruflichen Bildung sowie sozialen Integration gefährdet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  • Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L; RUPP ADHD/Anxiety Study Group (2005) Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry 44(5): 418–27

    Article  PubMed  Google Scholar 

  • Ahmann PA, Theye FW, Berg R, Linquist AJ, Van Erem AJ, Campbell LR (2001) Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects. Pediatrics 107: E10

    Article  PubMed  CAS  Google Scholar 

  • Aman MG, Binder C, Turgay A (2004) Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. J Child Adolesc Psychopharmacol 14: 243–54

    Article  PubMed  Google Scholar 

  • Amiri S, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Kahbazi M, Akhondzadeh S (2008) Modafinil as a treatment for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry 32: 145–149

    Article  PubMed  CAS  Google Scholar 

  • Angold A, Costello EJ, Erkanli A (1999) Comorbidity. J Child Psychol Psychiatry 40: 57–87

    Article  PubMed  CAS  Google Scholar 

  • Antkowiak R, Rajewski A (1998) Administration of moclobemide in children with attention deficit hyperactivity disorder Psychiatry Pol 30: 751–757

    Google Scholar 

  • Arabgol F, Panaghi L, Hebrani P (2008) Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder. Eur Child Adolesc Psychiatry. Epub ahead of print

    Google Scholar 

  • Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15: 476–495

    Article  PubMed  Google Scholar 

  • Banaschewski T, Döpfner M, Rothenberger A, Steinhausen HC (2008a) Editorial: Kommentar zu den Europäischen Leitlinien zum Einsatz langwirksamer Medikamente zur Behandlung der hyperkinetischen Störungen. Z Kinder-Jugendpsychiatr 36: 77–79

    Article  CAS  Google Scholar 

  • Banaschewski T, Coghill D, Santosh P, Zuddas A, Aserson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone S, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJS, Taylor E (2008b) Langwirksame Medikamente zur Behandlung der hyperkinetischen Störungen. Eine systematische Übersicht und europäische Behandlungsrichtlinien. Teil 1: Übersicht und Empfehlungen. Z Kinder-Jugendpsychiatr 36: 36: 81–95

    Article  Google Scholar 

  • Banaschewski T, Coghill D, Santosh P, Zuddas A, Aserson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone S, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJS, Taylor E (2008c) Langwirksame Medikamente zur Behandlung der hyperkinetischen Störungen. Eine sytematische Übersicht und europäische Behandlungsrichtlinien. Teil 2: ein quantitativer Vergleich der langwirksamen Präparate. Z Kinder-Jugend-psychiatr 36: 97–106

    Article  Google Scholar 

  • Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Ardnt SV, Herrmann KJ, Schumacher E (1995) Bupropion versus methylphenidatein the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34: 349–657

    Article  Google Scholar 

  • Benjamin E, Salek S (2005) Stimulant-atypical antipsychotic interaction and acute dystonia. J Am Acad Child Adolesc Psychiatry 44: 510–512

    Article  PubMed  Google Scholar 

  • Berkovitch M, Pope E, Phillips J, Koran G (1995) Pemolin-associated fulminant liver failure: testing the evidence of causation. Clin Pharmacol Ther 57: 696–698

    Article  PubMed  CAS  Google Scholar 

  • Biederman J, Pliszka SR (2008) Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. J Pediatr 152: 394–399

    Article  PubMed  CAS  Google Scholar 

  • Biederman J, Gastfriend DR, Jellinek (1986) Desipramine in the treatment of children with attention deficit disorder. J Clin Psychopharmacol 6: 359–363

    PubMed  CAS  Google Scholar 

  • Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS (1989a) A double-blind placebo controlled study of desipramine in the treatment ADD: I. Efficiacy. J Am Acad Child Adolesc Psychiatry 28: 777–789

    PubMed  CAS  Google Scholar 

  • Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS, Gold A (1989b) A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovaskular findings. J Am Acad Child Adolesc Psychiatry 28: 903–911

    PubMed  CAS  Google Scholar 

  • Bundesärztekammmer Vorstand (Hrsg) (2007) Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) Stellungnahme auf Empfehlung des Wissenschaftlichen Beirats. Deutscher Ärzte Verlag, Köln

    Google Scholar 

  • Cantwell DP (1996) Attention deficit disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 35: 978–987

    Article  PubMed  CAS  Google Scholar 

  • Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ (1995) Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette’s syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 34: 1140–1146

    Article  PubMed  CAS  Google Scholar 

  • Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A, Weller RA, Khayrallah M, Ascher J (1996) Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 35: 1314–1321

    Article  PubMed  CAS  Google Scholar 

  • Connor DF, Barkley RA, Davis HT (2000) A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr (Phila) 39: 15–25

    Article  CAS  Google Scholar 

  • Daviss WB, Patel NC, Robb AS, McDermott MP, Bukstein OG, Pelham WE Jr, Palumbo D, Harris P, Sallee FR (2008) Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry 47: 189–198

    Article  PubMed  Google Scholar 

  • Döpfner M, Lehmkuhl G (2003) Methylphenidat Retard. Editorial. ADHS Report. Referate für Klinik und Praxis 4: 1–8

    Google Scholar 

  • Döpfner M, Lehmkuhl G., Schepker R, Frölich J (2007) Hyperkinetische Störungen. In: Deutsche Gesellschaft für Kinder-und Jugendpsychiatrie und Psychotherapie, Bundesarbeitsgemeinschaft Leitender Klinikärzte für Kinder-und Jugendpsychiatrie und Psychotherapie und Bundesverband der Ärzte für Kinder-und Jugendpsychiatrie und Psychotherapie (Hrsg) Leitlinien zu Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes-und Jugendalter, 5. überarb. und erw. Aufl. Deutscher Ärzte-Verlag, Köln, 239–254

    Google Scholar 

  • Eggers C, Rothenberger A, Berghaus U (1988) Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 237: 223–229

    Article  PubMed  CAS  Google Scholar 

  • Elia J, Borcherding BG, Rapoport JL, Keysor CS (1991) Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders. Psychiatry Res 36: 141–155

    Article  PubMed  CAS  Google Scholar 

  • Findling RL, Newcorn JH, Malone RP, Waheed A, Prince JB, Kratochvil CJ (2007) Pharmacotherapy of aggression in a 9-year-old with ADHD. J Am Acad Child Adolesc Psychiatry 46: 653–658

    Article  PubMed  Google Scholar 

  • Geller D, Donnelly C, Lopez F, Rubin R, Newcorn J, Sutton V, Bakken R, Paczkowski M, Kelsey D, Sumner C (2007) Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry 46: 1119–1127

    Article  PubMed  Google Scholar 

  • Gerlach M, Rothenhöfer S, Mehler-Wex C, Fegert JM, Schulz E, Wewetzer C, Warnke A (2006) Therapeutisches Drug-Monitoring in der Kinder-und Jugendpsychiatrie: Grundlagen und Empfehlungen. Z Kinder Jugendpsychiatr Psychother 34: 5–13

    Article  PubMed  Google Scholar 

  • Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, McGough J, Wigal S, Wigal T, Vitiello B, Skrobala A, Posner K, Ghuman J, Cunningham C, Davies M, Chuang S, Cooper T (2006) Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45: 1284–93

    Article  PubMed  Google Scholar 

  • Gualtieri CT, Evans RW (1988) Motor performance in hyperactive children treated with imipramine. Percept Mot Skills 66: 763–769

    PubMed  CAS  Google Scholar 

  • Günther T, Herpertz-Dahlmann B, Jolles J, Konrad K (2006) The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorder. J Child Adolesc Psychopharmacol 16: 725–735

    Article  PubMed  Google Scholar 

  • Handen BL, Feldman HM, Lurier A, Murray PJ. (1999) Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD. J Am Acad Child Adolesc Psychiatry 38: 805–812

    Article  PubMed  CAS  Google Scholar 

  • Häßler F, Göhre C, Irmisch G (2003) In: Lehmkuhl U (Hrsg) Psychotherapie und Psychopharmakotherapie im Kindes-und Jugendalter. Indikation, Effekte, Verlauf. Vandenhoeck & Ruprecht, Göttingen, 100–107

    Google Scholar 

  • Heger S, Trott GE, Meusers M, Schulz E, Rothenberger A, Rettig K, Medori R, Schreiner A, Remschmidt H als Vertreter der deutschen C-2000-045-Studiengruppe (2006) Umstellung von einem unretardierten auf ein retardiertes Methylphenidatpräparat: Eine multizentrische offene Studie an Kindern mit ADHS. Z Kinder-Jugendpsychiatr Psychother 34: 257–265

    Article  PubMed  Google Scholar 

  • Hunt RD, Arnsten AF, Asbell MD (1995) An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorer. J Am Acad Child Adolesc Psychiatry 34: 50–54

    Article  PubMed  CAS  Google Scholar 

  • Jacob CP, Romanos J, Dempfle A, Heine M, Windemuth-Kieselbach C, Kruse A, Reif A, Walitza S, Romanos M, Strobel A, Brocke B, Schäfer H, Schmidtke A, Böning J, Lesch KP (2007) Comorbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci 257: 309–317

    Article  PubMed  Google Scholar 

  • Jans T, Kreiker S, Warnke A (2008) Multimodale Therapie der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Kindesalter. Nervenarzt 79: 791–800

    Article  PubMed  CAS  Google Scholar 

  • Jensen PS, Martin D, Cantwell DP (1997) Comorbidity in ADHD: implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry 36: 1065–1079

    Article  PubMed  CAS  Google Scholar 

  • Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B (2001) ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40: 147–58

    Article  PubMed  CAS  Google Scholar 

  • Kerdar MS, Scheuerpflug P, Srdinko P, Wewetzer Ch, Warnke A, Romanos M (2007) EEG-Veränderungen unter Methylphenidat — eine Pilotstudie. Z Kinder-Jugendpsychiatr 35: 247–255

    Article  Google Scholar 

  • Kratochvil CJ, Vitiello B, Brent D, Bostic JQ, Naylor MW (2006) Selecting an antidepressant for the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 45: 371–373

    Article  PubMed  Google Scholar 

  • Krause K-H, Krause J (2000) Ist Methylphenidat bei Komorbidität von Epilepsie und Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung kontraindiziert oder nicht? Akt Neurologie 27: 72–76

    Article  Google Scholar 

  • Lehmkuhl G, Poustka F, Schmidt MH (2007) Behandlung von ADHS mit Atomoxetin. Empfehlung zur Medikamentenumstellung von Stimulanzien auf Atomoxetin. Monatsschr Kinderheilkd 155: 645–648

    Article  Google Scholar 

  • Lyseng-Williamson KA, Keating GM (2002) Extended-release methylphenidate (Ritalin LA). Drugs 62: 2251225–9

    Google Scholar 

  • Malhotra S, Santosh PJ (1998) An open clinical trial of buspirone in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 37: 364–371

    Article  PubMed  CAS  Google Scholar 

  • Maloney MJ, Schwam JS (1995) Clonidine and sudden death. Pediatrics 96: 1176–1177

    PubMed  CAS  Google Scholar 

  • Markowitz JS, Patrick KS (2001) Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder. Clin Pharmacokinet 40: 753–771

    Article  PubMed  CAS  Google Scholar 

  • McCormick LH, Rizzuto GT, Khuckles HB (1994) A pilot study of buspirone in attention-deficit hyperactivity disorder. Arch Fam Med 3: 68–70

    Google Scholar 

  • Mohammadi MR, Ghanizadeh A, Alaghband-Rad J, Tehranidoost M, Mesgarpour B, Soori H (2004) Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial. J Child Adolesc Psychopharmacol 14: 418–25

    Article  PubMed  Google Scholar 

  • MTA Cooperation Group (1999a) Multimodal treatment Study of Children with ADHD. A 14 month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56: 1073–1086

    Article  Google Scholar 

  • MTA Cooperation Group (1999b) Multimodal treatment Study of Children with ADHD. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56: 1088–1096

    Article  Google Scholar 

  • MTA Cooperation Group (2004) National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 113: 754–761

    Article  Google Scholar 

  • Nehra A, Mullik F, Ishak KG, Zimmerman HJ (1990) Pemoline associated hepatic injury. Gastroenterology 99: 1517–1519

    PubMed  CAS  Google Scholar 

  • Palumbo DR, Sallee FR, Pelham WE Jr, Bukstein OG Daviss WB, McDermott MP (2008) Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry 47: 180–188

    Article  PubMed  Google Scholar 

  • Pearson DA, Santos CW, Roache JD, Casat CD, Loveland KA, Lachar D, Lane DM, Faria LP, Cleveland LA (2003) Treatment effects of Methylphenidate on behavioral adjustment in children with mental retardation and ADHD. J Am Acad Child Adolesc Psychiatry 42: 209–216

    Article  PubMed  Google Scholar 

  • Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J (1999) A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pediatrics 103: e43

    Article  PubMed  CAS  Google Scholar 

  • Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, McCracken JT, Swanson JM, Lopez M (2006) Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder. The Texas Children’s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45: 642–657

    Article  PubMed  Google Scholar 

  • Popper CW (1997) Antidepressants for ADHD. J Clin Psychiatry [Suppl 14] 58: 14–29

    Google Scholar 

  • Rapoport JL, Quinn PO, Bradbard G, Riddle KD, Brooks E (1974) Imipramine and methylphenidate treatments of hyperactive boys: a double blind comparison. Arch Gen Psychiatry 30: 789–793

    PubMed  CAS  Google Scholar 

  • Romanos M, Schwenck C, Walitza S (2008) Diagnostik der ADHS im Kindes-und Jugendalter. Nervenarzt 79: 782–790

    Article  PubMed  CAS  Google Scholar 

  • Rubinstein S, Malone MA, Roberts W, Logan WJ (2006) Placebo-controlled study examining effects of selegiline in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 16: 404–415

    Article  PubMed  Google Scholar 

  • Rugino TA, Copley TC (2001) Effects of modafinil in children with attention-deficit/hyperactivity disorder. An open label study. J Am Acad Child Adolesc Psychiatry 40: 230–235

    Article  PubMed  CAS  Google Scholar 

  • Santosh PJ, Taylor E (2000) Stimulant drugs. Eur Child Adolesc Psychiatry [Suppl 1] 9: 127–143

    Google Scholar 

  • Sinzig J, Döpfner M, Lehmkuhl G; German Methylphenidate Study Group, Ueber H, Schmeck K, Poustka F, Gerber WD, Günter M, Knölker U, Gehrke M, Hässler F, Resch F, Brünger M, Ose C, Fischer R (2007) Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 4: 421–432

    Article  Google Scholar 

  • Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AF, Cohen DJ, Leckman JF (2001) A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158: 1067–1074

    Article  PubMed  CAS  Google Scholar 

  • Schwenck C, Walitza S, Warnke A (2007) Komorbide Störungen bei ADHS im Kindes-und Jugendalter und ihre Therapie. In: Freitag CM, Retz W (Hrsg) ADHS und komorbide Erkrankungen. Kohlhammer, Stuttgart, 28–40

    Google Scholar 

  • Spencer TJ, Abikoff HB, Connor DF, Biederman J, Pliszka SR, Boellner S, Read SC, Pratt R (2006) Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. Clin Ther 28: 402–418

    Article  PubMed  CAS  Google Scholar 

  • Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, Clevenger B, Davies M, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Owens EB, Pelham WE, Schiller E, Severe JB, Simpson S, Vitiello B, Wells K, Wigal T, Wu M (2001) Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40: 168–179

    Article  PubMed  CAS  Google Scholar 

  • Taylor FB, Russo J (2000) Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. J Child Adolesc Psychopharmacol 10: 311–320

    Article  PubMed  CAS  Google Scholar 

  • Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European Clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry 1 [Suppl 1] 13: 17–30

    Google Scholar 

  • Tehrani-Doost M, Moallemi S, Shahrivar Z (2008) An open-label trial of reboxetine in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 18: 179–184

    Article  PubMed  Google Scholar 

  • Toren P, Ratner S, Weizman A, Lask M, Ben-Amitay G, Laor N (2007) Reboxetine maintenance treatment in children with attention-deficit/hyper-activity disorder: a long-term follow-up study. J Child Adolesc Psychopharmacol 17: 803–812

    Article  PubMed  Google Scholar 

  • Trott GE, Menzel M, Friese HJ, Nissen G (1991) Wirksamkeit und Verträglichkeit des selektiven MAO-A-Inhibitors Moclobemid bei Kindern mit hyperkinetischem Syndrom. Z Kinder Jugendpsychiatr 19: 248–53

    PubMed  CAS  Google Scholar 

  • Warnke und Walitza (2004) Methylphenidat in der Behandlung der Aufmerksamkeit-Defizit-Hyperaktivitätsstörung. In: Schulte-Markwort M, Warnke A (Hrsg) Methylphenidat. Thieme, Stuttgart New-York, 14–33

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kinder- und Jugendpsychiatrischer Dienst des Kantons Zürich, Neumünsterallee 9, 8032, Zürich

    Prof. Dr. med. Dipl.-Psych. S. Walitza (Ärztliche Direktorin)

  2. Oberarzt der Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie, Universität Würzburg, Füchsleinstraße 15, 97080, Würzburg

    Dr. med. M. Romanos MD

  3. Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Julius-Maximilians-Universität, Füchsleinstraße 15, 97080, Würzburg

    Prof. Dr. med. A. Warnke (Direktor)

Authors
  1. Prof. Dr. med. Dipl.-Psych. S. Walitza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. M. Romanos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. med. A. Warnke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinik und Poliklinik für Kinder- und Jugendpsychiatrie, Würzburg, Deutschland

    Manfred Gerlach  & Andreas Warnke  & 

  2. Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie, Universität Ulm, Deutschland

    Claudia Mehler-Wex

  3. Kinder- und Jugendpsychiatrischer Dienst des Kantons Zürich, Zürich, Schweiz

    Susanne Walitza

  4. Kliniken der Stadt Köln, Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie, Köln, Deutschland

    Christoph Wewetzer

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag/Wien

About this chapter

Cite this chapter

Walitza, S., Romanos, M., Warnke, A. (2009). Aufmerksamkeits-Defizit-/Hyperaktivitäts-Störungen. In: Gerlach, M., Warnke, A., Mehler-Wex, C., Walitza, S., Wewetzer, C. (eds) Neuro-Psychopharmaka im Kindes- und Jugendalter. Springer, Vienna. https://doi.org/10.1007/978-3-211-79275-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-79275-9_15

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-79274-2

  • Online ISBN: 978-3-211-79275-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation